Bihua Chen - Mar 20, 2023 Form 4 Insider Report for MoonLake Immunotherapeutics (MLTX)

Role
10%+ Owner
Signature
/s/ Bihua Chen
Stock symbol
MLTX
Transactions as of
Mar 20, 2023
Transactions value $
$16,774,846
Form type
4
Date filed
3/22/2023, 05:07 PM
Previous filing
Dec 20, 2022
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLTX Class A Ordinary Shares Purchase $8.65M +447K +15.68% $19.36 3.3M Mar 20, 2023 See Footnotes F2, F3
transaction MLTX Class A Ordinary Shares Purchase $1.3M +63.7K +1.93% $20.42 3.36M Mar 20, 2023 See Footnotes F3, F4
transaction MLTX Class A Ordinary Shares Purchase $1.64M +78K +2.32% $21.08 3.44M Mar 20, 2023 See Footnotes F3, F5
transaction MLTX Class A Ordinary Shares Purchase $5.18M +239K +6.94% $21.70 3.68M Mar 21, 2023 See Footnotes F3, F6
holding MLTX Class A Ordinary Shares 3.22M Mar 20, 2023 See Footnotes F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Helix Holdings LLC is the record holder of these securities. Bihua Chen is the manager of Helix Holdings LLC and has voting and investment discretion with respect to the securities held of record by Helix Holdings LLC. Ms. Chen disclaims any beneficial ownership of the securities held by Helix Holdings LLC other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
F2 Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $18.81 to $19.80 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.
F3 Various funds (the "Cormorant Funds") managed by Cormorant Asset Management, LP are the record holders of these securities. Bihua Chen is the founder and managing member of Cormorant Asset Management, LP and has voting and investment discretion with respect to the ordinary shares held by the Cormorant Funds. Ms. Chen disclaims any beneficial ownership of such securities other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
F4 Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $19.81 to $20.80 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.
F5 Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $20.81 to $21.25 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.
F6 Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $21.09 to $22.00 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.